---
schema_version: "secwatch.filing_event.v1"
accession: "0001807120-25-000004"
form_type: "8-K"
ticker: "DSGN"
cik: "0001807120"
company_name: "Design Therapeutics, Inc."
filed_at: "2025-09-10T23:59:59+00:00"
generated_at: "2026-05-17T07:04:31.046104+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Design Therapeutics director resigns; Justin Gover appointed to board

## Summary
- Arsani William, M.D. resigned from board effective Sept 9, 2025, not due to any disagreement.
- Board appointed Justin Gover as Class III director with term ending at 2027 annual meeting.
- Gover also named chair of Compensation Committee.
- Gover receives annual cash retainers of $40,000 for board service and $12,000 as committee chair.
- Gover granted initial option for 30,000 shares vesting over 3 years and prorated grant of 15,833 shares vesting over 1 year.

## SEC filing metadata
- accession: 0001807120-25-000004
- form_type: 8-K
- ticker: DSGN
- cik: 0001807120
- company_name: Design Therapeutics, Inc.
- filed_at: 2025-09-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1807120/000180712025000004/0001807120-25-000004-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1807120/000180712025000004/dsgn-20250909.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001807120-25-000004
- JSON: https://secwatch.observer/filing/0001807120-25-000004.json
- Plain text: https://secwatch.observer/filing/0001807120-25-000004.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.